Clinical Trial Update: Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacodynamics and safety of single-dose sarilumab and tocilizumab in adults with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Sarilumab (sarilumab)
• Tocilizumab (tocilizumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED